ArticleInternational journal of clinical and experimental pathology2022

Myocyte enhancer factor 2D promotes hepatocellular carcinoma through AMOTL2/YAP signaling that inhibited by luteolin.

Qianqian Xu et al.PubMed ↗Full text ↗

No numbers read from the abstract.